FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer Surgery
Newswise — PHILADELPHIA—The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue…
Read more FDA Approves “Glowing Tumor” Imaging Drug to Aid Lung Cancer Surgery